Conclusion This review synthesizes current evidence to summarize the therapeutic potential and underlying mechanisms of nanozymes in IMIDs, while highlighting key challenges and future directions to guide the development and clinical translation of nanozyme-based therapies
27 rabbits were experimentally induced with a 5-mm bone defect and were then divided into three groups that were given MGF, or a control substance for 5 consecutive days
Available from: Accessed 31 Dec 2023 de Prada, P., Loveland-Curtze, J., & Brenchley, J
Quantitative proteomic analyses reveal that GPX4 downregulation during myocardial infarction contributes to ferroptosis in cardiomyocytes
Despite promising preclinical data, clinical trials in humans are extremely limited, and the compound remains largely experimental, with ongoing research required to fully characterize pharmacokinetics, optimal dosing, long-term safety, and potential off-target effects.
This wash is more than just a skincare product